The professional's guide to product selection
Antimuscarinic bronchodilator.
For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.
For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.
For prophylaxis of asthma with Seffalair Spiromax® 12.75/100 by inhalation of powder
Child 12–17 years: 1 inhalation twice daily.
Adult: 1 inhalation twice daily.
For prophylaxis of asthma with Seffalair Spiromax® 12.75/202 by inhalation of powder
Child 12–17 years: 1 inhalation twice daily.
Adult: 1 inhalation twice daily.
Long-acting selective beta2 agonist with corticosteroid.
Sereflo Ciphaler 50/250 for prophylaxis of asthma
• Over 12 years: 1 inhalation twice daily, reduced to 1 inhalation once daily, use reduced dose only if control maintained.
Sereflo 125
• Adult for moderate to severe asthma: two inhalations twice daily.
Sereflo 250
• Adult moderate to severe asthma: two inhalations twice daily.
Long-acting selective beta2 agonist with corticosteroid.
Seretide 100 Accuhaler
• 4 years and over for asthma prophylaxis: one inhalation twice daily, reduce to one inhalation daily if controlled.
Seretide 250 Accuhaler
• 12 years and over for asthma prophylaxis: one inhalation twice daily.
Seretide 500 Accuhaler
• 12 years and over for asthma prophylaxis: one inhalation twice daily.
• Adult for COPD with FEV1 in one second <60% of predicted: one inhalation twice daily.
Seretide 50 Evohaler
• 4 years and over for asthma prophylaxis: two puffs twice daily, reduce to two puffs once daily if controlled.
Seretide 125 Evohaler
• 12 years and over for asthma prophylaxis: two puffs twice daily.
Seretide 250 Evohaler
• 12 years and over for asthma prophylaxis: two puffs twice daily.
Long-acting selective beta2 agonist.
Reversible airways obstruction in patients requiring long-term regular bronchodilator therapy
Nocturnal asthma in patients requiring long-term regular bronchodilator therapy
Prevention of exercise-induced bronchospasm in patients requiring long-term regular bronchodilator therapy
Chronic asthma only in patients who regularly use an inhaled corticosteroid (not for immediate relief of acute asthma)
By inhalation of aerosol, or by inhalation of powder
• Child 5–11 years: 50 mcg, twice daily.
• Over 12 years: by inhalation, 50 mcg twice daily. Up to 100 mcg twice daily for more severe airway obstruction.
For COPD by inhalation of aerosol, or by inhalation of powder
• Adult: 50 mcg (2 puffs or 1 blister), twice daily.
Exhaling through the Shaker causes a steel ball to vibrate in the casing, creating a movement in the airways that travels deep into the lungs and ‘shakes’ any stubborn mucus loose – where, with gentle coughing, patients can more comfortably expel it.
Stockists: Evergreen Nebulisers
A ceramic pipe filled with salt crystals from Himalayan caves. Its salty microclimate calms and cleanses the cells of the respiratory system. When using the pipe, the moisture of the passing inhaled air absorbs the micron-sized particles of the salt which then penetrate deep into the respiratory system to achieve beneficial effects. The active ingredient induces natural self-cleansing mechanisms that flush away the impurities from the surface of the cells. Salt particles also mechanically clean the air passages. It is recommended to use the pipe for 30 minutes per day. Refills are available.
Stockists: Sims Salt Pipes
A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.
Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.
Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.
Acapella combines the benefits of both PEP therapy and airway vibrations to mobilise pulmonary secretions and can be used in virtually any position allowing patients to move freely and sit, stand or recline.
It improves clearance of secretions and facilitates the opening of airways in patients with lung diseases with secretory problems, such as COPD, asthma and cystic fibrosis. Colour-coded units (green for high- flow, blue for low) help customise treatment for each patient based on their clinical needs. The Acapella frequency and flow resistance can be adjusted simply by turning an adjustment dial.
Stockists: Smiths Medical, Henleys Medical Supplies.
Long-acting selective beta2 agonist
Reversible airways obstruction in patients requiring long-term regular broncodilator therapy
Nocturnal asthma in patients requiring long-term regular bronchodilator therapy
Prevention of exercise-induced bronchospasm in patients requiring long-term regular bronchodilator therapy
Chronic asthma only in patients who regularly use inhaled corticosteroid (not for immediate relief of acute asthma)
• Child 5–11 years: 50 mcg, twice daily.
• Over 12 years: by inhalation, 50 mcg twice daily. Up to 100 mcg twice daily for more severe airway obstruction.
For COPD
• Adult: 50 mcg, twice daily.